Literature DB >> 11343625

QT interval variability in panic disorder patients after isoproterenol infusions.

R Pohl1, V K Yeragani.   

Abstract

Anxiety symptoms are associated with a marked increase in sudden cardiac death, suggesting an abnormality in the autonomic control of the heart. We examined the effects of sympathetic stimulation on QT interval variability in panic disorder patients by infusing the ss-adrenergic agonist isoproterenol in 6 panic disorder patients and 11 normal subjects. The ECG signal was analysed before the infusion and after 5 min after the infusion was started. The outcome measures were the QT variability normalized for mean QT interval (QTvm) and the QT variability index (QTvi), a measure of QT variability normalized by the concomitant heart rate variability. Patients with panic disorder had more variability in QT interval duration than normal controls and this variability was increased further by sympathetic stimulation with isoproterenol. The isoproterenol-associated increase in QT interval occurred in controls in the absence of significant anxiety. However, on one of two measures, the increase in QT interval variability was greater in patients with panic disorder, suggesting a greater sensitivity to isoproterenol or to isoproterenol-induced anxiety.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343625     DOI: 10.1017/S146114570100219X

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  5 in total

Review 1.  Anxiety and Cardiovascular Disease Risk: a Review.

Authors:  Phillip J Tully; Nathan J Harrison; Peter Cheung; Suzanne Cosh
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

2.  Beat-to-beat heart rate and QT variability in patients with congestive cardiac failure: blunted response to orthostatic challenge.

Authors:  Nagaraj Desai; D S Raghunandan; Mallika Mallavarapu; Ronald D Berger; Vikram K Yeragani
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

3.  Mood states, sympathetic activity, and in vivo beta-adrenergic receptor function in a normal population.

Authors:  Bum-Hee Yu; Eun-Ho Kang; Michael G Ziegler; Paul J Mills; Joel E Dimsdale
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

4.  QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology.

Authors:  Mathias Baumert; Alberto Porta; Marc A Vos; Marek Malik; Jean-Philippe Couderc; Pablo Laguna; Gianfranco Piccirillo; Godfrey L Smith; Larisa G Tereshchenko; Paul G A Volders
Journal:  Europace       Date:  2016-01-27       Impact factor: 5.214

5.  Panic disorder and incident coronary heart disease: a systematic review and meta-analysis protocol.

Authors:  Phillip J Tully; Gary A Wittert; Deborah A Turnbull; John F Beltrame; John D Horowitz; Suzanne Cosh; Harald Baumeister
Journal:  Syst Rev       Date:  2015-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.